Literature DB >> 22178890

Target discovery from data mining approaches.

Yongliang Yang1, S James Adelstein, Amin I Kassis.   

Abstract

Data mining of available biomedical data and information has greatly boosted target discovery in the 'omics' era. Target discovery is the key step in the biomarker and drug discovery pipeline to diagnose and fight human diseases. In biomedical science, the 'target' is a broad concept ranging from molecular entities (such as genes, proteins and miRNAs) to biological phenomena (such as molecular functions, pathways and phenotypes). Within the context of biomedical science, data mining refers to a bioinformatics approach that combines biological concepts with computer tools or statistical methods that are mainly used to discover, select and prioritize targets. In response to the huge demand of data mining for target discovery in the 'omics' era, this review explicates various data mining approaches and their applications to target discovery with emphasis on text and microarray data analysis. Two emerging data mining approaches, chemogenomic data mining and proteomic data mining, are briefly introduced. Also discussed are the limitations of various data mining approaches found in the level of database integration, the quality of data annotation, sample heterogeneity and the performance of analytical and mining tools. Tentative strategies of integrating different data sources for target discovery, such as integrated text mining with high-throughput data analysis and integrated mining with pathway databases, are introduced. Published by Elsevier Ltd.

Entities:  

Year:  2011        PMID: 22178890     DOI: 10.1016/j.drudis.2011.12.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  7 in total

Review 1.  Efficacy-oriented compatibility for component-based Chinese medicine.

Authors:  Jun-hua Zhang; Yan Zhu; Xiao-hui Fan; Bo-li Zhang
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

Review 2.  In silico Methods for Identification of Potential Therapeutic Targets.

Authors:  Xuting Zhang; Fengxu Wu; Nan Yang; Xiaohui Zhan; Jianbo Liao; Shangkang Mai; Zunnan Huang
Journal:  Interdiscip Sci       Date:  2021-11-26       Impact factor: 3.492

3.  The HUPO proteomics standards initiative- mass spectrometry controlled vocabulary.

Authors:  Gerhard Mayer; Luisa Montecchi-Palazzi; David Ovelleiro; Andrew R Jones; Pierre-Alain Binz; Eric W Deutsch; Matthew Chambers; Marius Kallhardt; Fredrik Levander; James Shofstahl; Sandra Orchard; Juan Antonio Vizcaíno; Henning Hermjakob; Christian Stephan; Helmut E Meyer; Martin Eisenacher
Journal:  Database (Oxford)       Date:  2013-03-12       Impact factor: 3.451

4.  How We Think about Targeting RNA with Small Molecules.

Authors:  Matthew G Costales; Jessica L Childs-Disney; Hafeez S Haniff; Matthew D Disney
Journal:  J Med Chem       Date:  2020-03-26       Impact factor: 7.446

5.  A crowdsourcing workflow for extracting chemical-induced disease relations from free text.

Authors:  Tong Shu Li; Àlex Bravo; Laura I Furlong; Benjamin M Good; Andrew I Su
Journal:  Database (Oxford)       Date:  2016-04-17       Impact factor: 3.451

6.  Large-scale in-silico identification of a tumor-specific antigen pool for targeted immunotherapy in triple-negative breast cancer.

Authors:  Jessica Kaufmann; Nicolas Wentzensen; Titus J Brinker; Niels Grabe
Journal:  Oncotarget       Date:  2019-04-02

7.  The targeted inhibition of prostate cancer by iron-based nanoparticles based on bioinformatics.

Authors:  Feng Xiao; Jiayu Liu; Yongbo Zheng; Zhen Quan; Wei Sun; Yao Fan; Chunli Luo; Hailiang Li; Xiaohou Wu
Journal:  J Biomater Appl       Date:  2020-12-06       Impact factor: 2.646

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.